跳至主要内容
临床试验/NCT01711619
NCT01711619终止不适用

Interventional, Prospective, Multicenter, Randomized, Parallel-arm Study to Compare the Effectiveness of Peripheral Nerve Stimulation (PNS) Utilizing a Subcutaneous Lead Implant Technique (SQS) Plus Optimized Medical Management (OMM) Versus OMM Alone in Patients Suffering From Back Pain Due to Failed Back Surgery Syndrome (FBSS)

MedtronicNeuro52 个研究点 分布在 10 个国家目标入组 162 人开始时间: 2012年11月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
162
试验地点
52
主要终点
Effectiveness of Treatment on Reduction of Back Pain Intensity

研究概览

简要总结

The purpose of this study is to compare the effectiveness of peripheral nerve stimulation utilizing a subcutaneous lead implant technique (SQS) plus optimized medical management (OMM) versus OMM alone in patients suffering from back pain due to Failed Back Surgery Syndrome (FBSS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provides written Patient Informed Consent/Patient Information Sheet prior to study-related activities being conducted
  • ≥ 18 years of age at time of informed consent
  • Willing and available to attend visits as scheduled and to comply with the study protocol
  • Willing and able to undergo assessments as part of the evaluation for eligibility and endpoints
  • Willing and able to use the external neurostimulator, recharging equipment (if applicable), and patient programmer per the schedule required by the protocol
  • Diagnosed with FBSS (i.e.):
  • Has had persistent pain for 6 months following most recent anatomically correct, successful surgery AND
  • There are no further therapeutic surgical options available as assessed by appropriate investigation
  • Back pain is considered intractable and has been adequately treated (failed an appropriate trial of at least 3 different classes of back pain treatments (pharmaceutical and/or non-pharmaceutical))
  • Is an appropriate implant candidate for the SQS system

排除标准

  • Has been or is currently being treated with spinal cord stimulation, subcutaneous nerve stimulation, peripheral nerve stimulation or an implantable intrathecal drug delivery system
  • Evidence of an active disruptive psychiatric disorder that is significant enough to impact the perception of pain, compliance to intervention and/or ability to evaluate treatment outcome, as determined by the investigator
  • Has a pain condition unrelated to FBSS that is severe enough to overshadow the FBSS pain in the opinion of the investigator
  • Spinal instability or anatomic compression that requires further surgery
  • Spinal fusion at more than 3 vertebral levels
  • Currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound the results of this study
  • Allergic or has shown hypersensitivity to any materials of the device system which come in contact with the body
  • History of coagulation disorder or lupus erythematosus
  • Involved in current litigation regarding back pain

结局指标

主要结局

Effectiveness of Treatment on Reduction of Back Pain Intensity

时间窗: 9 months

Percentage of participants who responded to the treatment, where response was defined as ≥ 50% reduction in back pain intensity as measured by Visual Analog Scale from baseline to the 9-month follow-up visit. Pain intensity was measured by a 100 mm Visual Analog Scale, with 0 representing no pain and 100 representing the worst pain imaginable.

次要结局

  • Average Change in Back Pain Intensity(6 and 9 months)
  • Back Pain Responder Rate (≥50%) at 6 Months(6 months)
  • Back Pain Responder Rate (≥30%) at 9 Months(9 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (52)

Loading locations...

相似试验